Long-term quality of life after refractory cardiac arrest requiring ECLS: A 10 years single-center analysis - 25/06/25
, Lucie Gaide-Chevronnay a, Cecile Blacque a, Stephane Priem a, Geraldine Dessertaine a, Timothee Abaziou a, Amelie Hebrard a, Fahd Bennani b, Alexandre Sebestyen b, Pierre Albaladejo a, cAbstract |
Background |
Impact of V-A ECMO to treat cardiac arrest on quality of life is unclear. a
Methods |
In 2021, all patients treated in the intensive care unit (ICU) of our tertiary university hospital for cardiac arrest requiring V-A ECMO from 2006 to 2018, were contacted by mail and by phone in order to complete an SF-36 form. Quality of life was then compared with reference values (patients with cardiovascular diseases, patients with ischemic heart disease, ICU-survivor patients at 36 months after discharge, and cardiac arrest survivors not treated with V-A ECMO).
Results |
Among 45 survivors, 25 patients completed the SF-36 form with a mean time for assessing quality of life of 6.9 ± 2.3 years. Sub-scores were globally comparable with those observed in referent cohorts.
Discussion |
Cardiac arrest marks the beginning of a medical journey that includes intensive care management and the onset of cardiac disease, often of ischemic origin. Our data suggest that quality of life of patients treated with V-A ECMO for cardiac arrest is comparable to those reported in referent cohorts (ICU-survivors, patients with cardiovascular diseases of ischemic heart disease, and cardiac arrest survivors not treated with mechanical circulatory support).
Conclusion |
Survivor patients who experienced cardiac arrest and treated with V-A ECMO presented a good long-term quality of life. Decision regarding V-A ECMO implantation should not be limited by concerns about patients’ future quality of life.
Le texte complet de cet article est disponible en PDF.Keywords : Veno-arterial ECMO, Intensive care, Quality of life, Cardiac arrest, Extracorporeal life support
Abbreviations : AKI, BMI, BP, CA, ELSO, GH, ICU, IHCA, MCS, MH, OHCA, PF, QoL, RE, RP, RRT, SF, SF-36, V-A ECMO, VT
Plan
Vol 44 - N° 4
Article 101516- août 2025 Retour au numéro
Article précédent
- Remimazolam for anesthesia in cardiac and noncardiac surgery. A narrative literature review and synthesis
- Jacopo D’Andria Ursoleo, Alice Bottussi, Gabor Erdoes, Jiapeng Huang, Fabrizio Monaco
- Peri-partum reference range for the point-of-care viscoelastic testing device Quantra® QStat in healthy pregnancy and non-haemorrhagic post-partum – A short communication
- Oliver Lukowiak, Agnès Le Gouez, Maxime Djebbour, Frédéric J. Mercier, Anne-Sophie Bouthors
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?